omega-n-methylarginine has been researched along with adenosine-5'-(n-ethylcarboxamide) in 4 studies
Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (adenosine-5'-(n-ethylcarboxamide)) | Trials (adenosine-5'-(n-ethylcarboxamide)) | Recent Studies (post-2010) (adenosine-5'-(n-ethylcarboxamide)) |
---|---|---|---|---|---|
4,411 | 344 | 336 | 1,333 | 4 | 133 |
Protein | Taxonomy | omega-n-methylarginine (IC50) | adenosine-5'-(n-ethylcarboxamide) (IC50) |
---|---|---|---|
Adenosine receptor A3 | Homo sapiens (human) | 0.0097 | |
Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.037 | |
Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.037 | |
Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.037 | |
Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 0.4498 | |
Adenosine receptor A2a | Homo sapiens (human) | 0.0336 | |
Adenosine receptor A2b | Rattus norvegicus (Norway rat) | 0.0175 | |
Adenosine receptor A1 | Homo sapiens (human) | 0.0007 | |
Adenosine receptor A2a | Rattus norvegicus (Norway rat) | 0.0513 | |
Adenosine receptor A1 | Gallus gallus (chicken) | 0.017 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Axe, FU; Bembenek, SD; Butler, CR; Coles, F; Dunford, PJ; Edwards, JP; Fourie, AM; Grice, CA; Karlsson, L; Lundeen, K; Riley, JP; Savall, BM; Tays, KL; Wei, J; Williams, KN; Xue, X | 1 |
Hargittai, PT; Lieberman, EA; Mustafa, SJ; Olanrewaju, HA | 1 |
Abdel-Rahman, AA; el-Mas, MM; Fahim, M; Mustafa, SJ | 1 |
Ali, S; Metzger, WJ; Mustafa, SJ; Olanrewaju, HA | 1 |
4 other study(ies) available for omega-n-methylarginine and adenosine-5'-(n-ethylcarboxamide)
Article | Year |
---|---|
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Catalysis; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship | 2008 |
Role of endothelium in hyperpolarization of coronary smooth muscle by adenosine and its analogues.
Topics: 2-Chloroadenosine; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Arginine; Coronary Vessels; Dose-Response Relationship, Drug; Endothelium, Vascular; Humans; In Vitro Techniques; Indomethacin; Membrane Potentials; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; omega-N-Methylarginine; Swine; Theophylline; Vasodilator Agents | 1995 |
Influence of aortic baroreceptor denervation on adenosine receptor-mediated relaxation of isolated rat aorta.
Topics: Acetylcholine; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Aorta, Thoracic; Arginine; Blood Pressure; Endothelium, Vascular; Heart Rate; In Vitro Techniques; Male; Muscle Denervation; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; omega-N-Methylarginine; Phenylephrine; Pressoreceptors; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Theophylline | 1994 |
Adenosine receptor-mediated relaxation of rabbit airway smooth muscle: a role for nitric oxide.
Topics: 2-Chloroadenosine; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Arginine; Bronchi; Dose-Response Relationship, Drug; Epithelium; In Vitro Techniques; Muscle Contraction; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nitric Oxide; omega-N-Methylarginine; Phenethylamines; Potassium Chloride; Purinergic P1 Receptor Agonists; Rabbits; Receptors, Purinergic P1 | 1997 |